Background Severe mental illness (SMI; schizophrenia, bipolar disorders (BDs), and other
nonorganic psychoses) is associated with increased risk of cardiovascular disease (CVD) …

For over half a century, it has been widely known that lithium is the most efficacious
treatment for bipolar disorder. Yet, despite this, its prescription has consistently declined …

Objective: Pharmacological options for treating bipolar disorder have increased over the
past 20 years, with several second-generation antipsychotics receiving regulatory approval …

Background While clinical trial evidence has firmly established the efficacy of several
atypical antipsychotics (AAPs) for treating bipolar depression, no randomized controlled …

Background Lithium is considered the gold standard treatment for bipolar disorder (BD).
Current clinical guidelines and scientific evidence support its use as a first-line treatment in …

Background Lithium has long been considered the gold-standard pharmacological
treatment for the maintenance treatment of bipolar disorders (BD) which is supported by a …

Background Lithium remains the gold-standard medication for acute and prophylactic
treatment of bipolar disorder. Understanding clinicians' practices and patients' experiences …

Background During over half a century, science has shown that lithium is the most
efficacious treatment for bipolar disorder but despite this, its prescription has consistently …

Objectives There is limited information on the characteristics of older adults with bipolar
disorder (OABD) treated with lithium, along with safety concerns about its use by older …

Lithium remains an effective option in the treatment of bipolar disorder (BD). Thus, we aim to
characterize the pharmaco-epidemiological patterns of lithium use internationally over time …